Preventing ubiquitination of BK channels by pharmacologic or genetic interference of the CRL4A enzyme complex leads to increased trafficking of BK channels to the neuronal cell membrane and a higher incidence of seizure induction and epilepsy in mice. Here, KCNMA1 is linked to epilepsy.